Scientific Congresses retweeted
We’re looking forward to #ASCO24 next month, where we’ll highlight our progress in advancing potential standards of care across our key tumor areas and core scientific modalities. Learn more here: on.pfizer.com/49YUGUL
Scientific Congresses retweeted
Visit our poster presentation at #AHSAM 2023 to learn about new data on utilization patterns of a CGRP receptor antagonist for treatment of migraine and pooled data of an intranasal migraine agent in adults with and without baseline nausea. #PfizerMedical #NeuroTwitter #Migraine
Pfizer’s Poster Presentation at AHS
Scientific Congresses retweeted
Excited to be at #AHSAM 2023 where we will be sharing our latest scientific research with the #neurology community. Visit our scientific sessions and poster presentations to learn about our latest data in migraine.
#PfizerMedical #Migraine
Pfizer’s Scientific Research at AHS
Scientific Congresses retweeted
At #AANAM 2023 we are presenting our latest data in the acute treatment of #Migraine. Stop by our scientific session to hear about new clinical trial data for an intranasal CGRP receptor antagonist in patients with migraine. Learn more at on.pfizer.com/3N9J4WX #PfizerMedical
Pfizer’s Scientific Session at AAN
Scientific Congresses retweeted
Bruce Altevogt, Pfizer will present a poster “AMR register: creation of a new, freely accessible platform for antimicrobial susceptibility data sharing” at ECCMID 2023, April 15, 11am, Arena 1.
@pfizer @VivliCenter @ParatekPharma #antimicrobialresistance #AMR
Scientific Congresses retweeted
ARM had great conversation with other experts at the @WorldHealthSmt roundtable with @pfizer this week where we discussed health system barriers and potential solutions to gene therapy delivery and access.
#WHS2022 #GeneTherapy
Scientific Congresses retweeted
Today, I updated @Pfizer colleagues on our pledge to donate the equivalent of all profits from our sales in Russia to causes providing humanitarian support to the people of Ukraine. Proud to say we’re making good on this promise. View the message here: on.pfizer.com/39EDjQ1
Scientific Congresses retweeted
Pfizer is committed to helping patients through research. At #ASCO22, we are proud to have 26 presentations, including 2 oral presentations. bit.ly/3LIJaR6
Pfizer_OncMed_Evolved Twitter_Video_V2.mp4
Scientific Congresses retweeted
Pfizer Oncology is committed to researching #CancerTreatments for individuals with genitourinary cancers. Join us February 11-13 at ASCO #GU21 to see our latest research.
bit.ly/3cRiiRc
Scientific Congresses retweeted
Unlike #COVID19, AMR is a predictable and preventable crisis – a problem we can't afford to ignore. Today, we're proud to be officially launching the #AMRActionFund. bit.ly/2CeJRnb
Scientific Congresses retweeted
“As the world mobilizes to combat the COVID-19 pandemic, the intersection of acute illnesses and chronic diseases presents new challenges to public health,” said Amrit Ray, MD, MBA, from @Pfizer Upjohn. #NCDAcademy #ACC20
Scientific Congresses retweeted
If you’re at #ECNP2018 in Barcelona, be sure to check out the Expert Science Exchange discussion from @Pfizer, with Stephen Stahl and Mohammad Alsuwaidan. Post is supported by Pfizer and does not imply ECNP’s endorsement of the content. ow.ly/CqxS30m0ASp
Scientific Congresses retweeted
Replying to @pfizer
Scientific Congresses retweeted
What Congress content would you like to see on our @PfizerCongress channel?
67%Educational resources
0%Scientific congress news
33%Event highlights
0%Access to treatment info
3 votes • Final results Scientific Congresses retweeted
What Congress content would you like to see on our @PfizerCongress channel? (please comment or DM us for anything not on the list)
0%Educational resources
0%Scientific congress news
100%Event highlights
0%Access to treatment info
1 votes • Final results Scientific Congresses retweeted
What Congress content would you like to see on our @PfizerCongress channel? (please comment or DM us for anything not on the list)
0%Educational resources
100%Scientific congress news
0%Event highlights
0%Access to treatment info
1 votes • Final results















